Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
Zacks.com on MSN4h
DexCom CGM Sensor Sales to Continue Despite FDA Warning LetterDXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
Investor's Business Daily on MSN3d
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedDexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
NSYNC entertainer diagnosed with rare form of diabetes that happens in adulthood but is more like Type 1 than Type 2.
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...
Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...
This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss how continuous glucose monitoring (CGM) adoption impacts clinical inertia and ...
(NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Renée Galá to its Board of Directors, effective March 6, 2025. Ms. Galá is an accomplished executive with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback